Chloe Nordquist is a national journalist for the E.W. Scripps Company. She has a passion for telling community stories and giving a voice to the voiceless. Chloe has had the opportunity to report across the world, as far as Milan and Berlin. Previously she worked at news stations in California’s Central Valley and Southwest Florida.
The Senate Committee on Health, Education, Labor and Pensions called the prices of the drugs “outrageously high” in the United States.
The popular Type 2 diabetes medication and weight loss drugs are made by Novo Nordisk. The demand in the U.S. caused a shortage. In an announcement Thursday, the Senate committee said the company charges Americans with Type 2 diabetes $969 a month for Ozempic. The same drug is sold for $155 in Canada and $59 in Germany.A study by Yale University earlier this year found both drugs can be manufactured for less than $5 a month.
Committee chair Bernie Sanders asked Novo Nordisk’s CEO for more transparency on how the price is determined in a letter to the company. Sanders wrote, in part, “As important as these drugs are, they will not do any good for the millions of patients who cannot afford them. Further, if the prices for these products are not substantially reduced they also have the potential to bankrupt Medicare, Medicaid, and our entire health care system. The United States Congress and the federal government cannot allow that to happen."
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
US Senate committee investigates pricing of Novo's Ozempic and WegovyUS Senate committee investigates pricing of Novo's Ozempic and Wegovy
続きを読む »
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.Before insurance, Novo Nordisk charges about $1,000 per month for Ozempic in the United States. In Germany, the company charges $59 a month for the same drug.
続きを読む »
US Senate committee investigates pricing of Novo's Ozempic and WegovyA U.S. Senate committee said on Wednesday it had launched an investigation into the prices of Novo Nordisk's diabetes and weight loss drugs Ozempic and Wegovy in the United States.
続きを読む »
Sen. Bernie Sanders launches Senate investigation into 'high' pricing of Ozempic, WegovySenator Berne Sanders is launching an investigation into the 'outrageously high prices' Novo Nordisk charges for the drugs.
続きを読む »
Sen. Bernie Sanders launches Senate investigation into 'high' pricing of Ozempic, WegovySenator Berne Sanders is launching an investigation into the 'outrageously high prices' Novo Nordisk charges for the drugs.
続きを読む »
Sen. Bernie Sanders launches Senate investigation into 'high' pricing of Ozempic, WegovySenator Berne Sanders is launching an investigation into the 'outrageously high prices' Novo Nordisk charges for the drugs.
続きを読む »